Houlihan Lokey, Inc.

Houlihan Lokey, Inc. (HLI) Market Cap

Houlihan Lokey, Inc. has a market capitalization of $9.62B.

Price: $139.25

-1.95 (-1.38%)

Market Cap: 9.62B

NYSE · time unavailable

CEO: Scott Joseph Adelson

Sector: Financial Services

Industry: Financial - Capital Markets

IPO Date: 2015-08-13

Website: https://www.hl.com

Houlihan Lokey, Inc. (HLI) - Company Information

Market Cap: 9.62B|Sector: Financial Services

Company Profile

Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as advise financial sponsors on various transactions. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; dispute resolution and expert testimony; and procuring debtor-in-possession financing. The Financial and Valuation Advisory segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution services. It serves corporations, institutions, and governments. The company was incorporated in 1972 and is headquartered in Los Angeles, California with offices in the United States, Europe, the Middle East, and the Asia-Pacific region.

Analyst Sentiment

73%
Strong Buy

From 10 Active Polls

1Y Forecast: $188.00

▲ +35.0% Potential Upside

Consensus Target Metrics

Low Bound

$160

Median

$193

High Bound

$211

Average

$188

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$188.00
▲ +35.01% Upside
Low Target
$160.00
15% Risk
Median Target
$193.00
39% Mid
High Target
$211.00
52% Max
Consensus
Buy
9 / 15 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)9,6179,52811,60713,74911,92110,69411,43210,4018,802
Enterprise Value ($M)8,9198,83111,04813,25811,56710,16111,06610,1418,787
Price to Earnings Ratio (P/E)21.7023.8624.9030.7530.5621.9329.9927.8024.74
Price/Earnings-to-Growth Ratio (PEG)2.853.444.352.902.33
Price to Sales Ratio (P/S)3.6714.9916.1920.8519.6916.0518.0218.0917.14
Price to Book Ratio (P/B)3.944.075.066.125.474.925.495.314.81
Price to Free Cash Flow Ratio (P/FCF)14.1033.2253.4842.59-82.3231.1043.6937.32-116.76
Enterprise Value to Sales (EV/Sales)13.8915.4120.1019.1115.2517.4417.6417.11
Enterprise Value to EBITDA (EV/EBITDA)13.6761.9459.2173.9580.2057.9669.8369.8774.05
Debt to Equity Ratio-1.070.210.220.190.200.200.210.220.24

HLI Growth Runway Model

Standard long term linear growth fade

Multi-Stage Discounted Cash Flow Sandbox

Market Price$139.25
Intrinsic Value$134.71
Market Alignment
Overvalued by 3.3%relative to calculated intrinsic value
9.00%
Exp: 5%5%
i

Growth runway slowdown

This value provides a time window for the growth rate to decline beyond Stage 1 toward the terminal rate. Longer windows are most useful for companies with high growth starting conditions or strong competitive advantages. This option stretches out the growth rate slowdown across 5, 10, or 15-year steps. A high-growth starting condition (exceeding a 25% initial growth rate) automatically applies a curve decay to simulate realistic, rapid market saturation.
i

Terminal growth rate

With long-term inflation between 3-5%, revenue must grow by that baseline to maintain flat real-world market share. This value sets the permanent terminal growth rate to factor into the valuation beyond the growth slowdown runway toward maturity.

3-Stage Financial Runway Horizon

🧠 Perpetuity Horizon Engine (Stage 3: Post-2036)

Terminal FCF Base$0.67B
Perpetuity TV Value$12.67B
Discounted TV (PV)$4.91B
TV Weighting %57.7%
⚠️
Financial Model Disclaimer & Risk Disclosure: This interactive scenario simulator is an educational sandbox provided strictly for informational and analytical research purposes. Core historical financial statements and consensus estimates are sourced directly via Financial Modeling Prep (FMP). All downstream outputs are entirely deterministic, hypothetical projections generated by combining automated mathematical formulas (including linear interpolation and Gaussian bell-curve decay models) with user-selected variables and third-party financial data inputs. Users assume all liability for trading decisions executed based on these sandbox calculations.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 HOULIHAN LOKEY INC CLASS A (HLI) — Investment Overview

🧩 Business Model Overview

Houlihan Lokey is a transaction-focused advisory firm. The company serves corporate and investor clients across major value-creation events—mergers and acquisitions, fairness opinions, restructuring, and valuation. Work flows from client origination (relationships and referrals), to mandate execution (analyst/modeling teams, industry specialists, and senior deal leadership), to fee realization (primarily success-based advisory fees and milestone-based deliverables).

A key feature of the model is that expertise is embedded in engagements: deal teams develop institutional knowledge about counterparties, assets, leverage profiles, and negotiation dynamics. That “knowledge continuity” creates client stickiness, supporting repeat mandates and cross-service opportunities (e.g., valuation informing restructuring or M&A negotiations).

💰 Revenue Streams & Monetisation Model

  • Transaction advisory (M&A / capital advisory): fees typically tied to completion and/or defined milestones, making revenue inherently cyclical with deal volume and credit conditions.
  • Restructuring and advisory: mandates often respond to credit stress and capital structure complexity; fees can be milestone-driven and tied to outcomes across creditor and equity negotiations.
  • Valuation & fairness / dispute-related services: more recurring in nature than pure deal-completion work, supported by ongoing requirements for financial reporting, litigation, and purchase/sale processes.
  • Consulting and other professional services: supplemental services that leverage the same research and modeling capabilities while broadening the client footprint.

Margin drivers are primarily (i) utilization of senior and junior professionals, (ii) project economics on complex mandates, and (iii) compensation structure (variable components tied to performance and realization). Because the firm’s cost base is heavily labor-driven, operating leverage depends on deal flow and the ability to keep high-quality staffing aligned with demand.

🧠 Competitive Advantages & Market Positioning

HLI’s durable moat is best characterized as switching costs and intangible client trust rather than technology-led defensibility. Specialized expertise in valuation and restructuring creates repeat engagement dynamics: once a client entrusts a mandate, the incumbent benefits from accrued knowledge, established processes, and a proven track record under time-sensitive and high-scrutiny situations.

  • Greenhill & Co. (GHL): competes for advisory mandates and restructuring work, typically with a boutique positioning. HLI’s competitive focus emphasizes scale in valuation and restructuring depth, supporting broader cross-sell across investor and corporate clients.
  • Lazard (LAZ): competes strongly in high-profile M&A and strategic advisory, with a brand anchored in senior-led deal execution. HLI often differentiates through more pronounced specialization in restructuring and valuation services where credibility and documented work product matter.
  • Evercore (EVR): competes in M&A and strategy advisory with a professional-services model and industry coverage. HLI’s relative positioning leans toward credit-sensitive and technically complex advisory areas that favor established specialists and proven outcomes.

Overall, HLI operates with a focus on advisory segments where credibility, modeling rigor, and execution track record are central. These attributes are difficult for new entrants to replicate quickly, reinforcing client retention and widening the pipeline through referrals.

🚀 Multi-Year Growth Drivers

Across a 5–10 year horizon, growth is supported by structural demand for independent advisory in complex corporate actions:

  • Persistent deal complexity: multinational transactions, heightened diligence requirements, and evolving stakeholder expectations increase the need for high-quality valuation and advisory.
  • Credit cycle re-normalization: restructuring and capital structure advisory demand expands in periods of leverage stress, refinancing pressure, and covenant renegotiations—segments where specialized expertise commands mandates.
  • Valuation-driven transactions and reporting needs: fair value measurement, impairment considerations, and transaction-related valuation work maintain baseline demand independent of pure M&A cycles.
  • Private capital activity: private equity and private markets increase the frequency of portfolio restructurings, exits, and complex acquisition modeling—creating recurring sources of valuation and advisory work.
  • Cross-service client relationships: mandates in restructuring, valuation, and M&A can share analysts, templates, and data sets, enabling efficiency in onboarding new projects for existing clients.

TAM expansion is less about “new markets” and more about increased penetration of advisory outsourcing and the need for specialized independent counsel as transaction and balance-sheet complexity rises.

⚠ Risk Factors to Monitor

  • Advisory cyclicality: transaction volumes and credit stress severity drive fee activity; downturns can reduce utilization and revenue.
  • Competition from banks and boutiques: large-cap investment banks and specialized boutiques can win mandates through pricing, balance-sheet relationships, or sector specialization.
  • Execution and reputational risk: advisory outcomes and credibility are paramount; client losses or public disputes can impair the pipeline.
  • Regulatory and compliance burdens: financial reporting requirements, professional conduct oversight, and marketing/solicitation rules can increase compliance costs and restrict certain practices.
  • Human capital concentration: as a professional-services firm, performance depends on recruiting, retaining, and scaling senior talent; compensation pressure can rise during tight labor markets.

📊 Valuation & Market View

Equity markets typically value advisory firms based on normalized earnings power rather than short-cycle earnings, given the business’s exposure to deal activity and credit conditions. Common valuation frameworks include earnings or enterprise-value-based multiples (e.g., EV/EBITDA or P&E-related measures) that reflect expected operating leverage, workforce scalability, and long-term fee capacity.

Key valuation drivers include (i) the durability of client relationships and mandate win rates, (ii) margin resilience through compensation discipline and utilization management, and (iii) balance between transaction-dependent revenue and more stable valuation/restructuring-related services.

🔍 Investment Takeaway

Houlihan Lokey’s long-term case rests on specialized expertise in valuation and restructuring and the resulting client switching costs tied to trust, documentation, and execution history. While revenue generation remains cyclical with capital markets and credit conditions, the firm’s positioning supports repeat engagement dynamics and cross-sell potential—factors that can sustain earnings capacity through market cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for HLI.

seekingalpha.com2026-06-05

Dividend Champion, Contender, And Challenger Highlights: Week Of June 7

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

businesswire.com2026-06-04

Houlihan Lokey Expands GP-Led Secondaries Capabilities into Real Estate With Senior Hire in Capital Solutions Group

NEW YORK--(BUSINESS WIRE)--Bodo Krug von Nidda has joined Houlihan Lokey in New York as a Managing Director in Capital Solutions. He will focus on real estate GP Secondaries.

gurufocus.com2026-06-01

Houlihan Lokey Expands Business Services Group With Strategic Senior Hire

Houlihan Lokey, Inc. (NYSE: HLI), the global investment bank, announced today that Dave Buscaglia has joined as a Managing Director in its Business Services Gro

businesswire.com2026-06-01

Houlihan Lokey Expands Business Services Group With Strategic Senior Hire

NEW YORK--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Dave Buscaglia has joined as a Managing Director in its Business Services Group. Based in New York, Mr. Buscaglia will cover the specialty consulting and risk services sectors. Mr. Buscaglia joins the firm following five years as a Managing Director in Stifel's Business Services Group. At Stifel, his coverage included professional services, including accounting, advisory, consulting, and.

newsfilecorp.com2026-05-27

Kaskela Law LLC Announces Investigation of Houlihan Lokey, Inc. (HLI) and Encourages Long-Term HLI Shareholders to Contact the Firm

Newtown Square, Pennsylvania--(Newsfile Corp. - May 27, 2026) - Kaskela Law LLC is investigating Houlihan Lokey, Inc. (NYSE: HLI) ("Houlihan Lokey") on behalf of the company's shareholders. The investigation seeks to determine whether Houlihan Lokey and/or the company's officers and directors violated the securities laws or breached their fiduciary duties to the company's investors in connection with recent corporate actions.

businesswire.com2026-05-11

Houlihan Lokey Grows Global Technology Group With Experienced Hire

NEW YORK--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, announced today that Eric Crowley has joined as a Managing Director in the firm's Global Technology Group. Based in San Francisco, Mr. Crowley will focus on consumer subscription software, consumer technology and ad-tech sectors for the firm. Mr. Crowley brings more than a decade of investment banking and operating experience advising founders, executives, and investors. At GP Bullhound, he led the firm's Co.

marketbeat.com2026-05-10

Houlihan Lokey Q4 Earnings Call Highlights

Houlihan Lokey NYSE: HLI reported record fiscal 2026 revenue and higher adjusted earnings, while management said uncertainty tied to geopolitical events and sector-specific pressures affected the timing of some transactions in the fourth quarter.

zacks.com2026-05-06

Compared to Estimates, Houlihan Lokey (HLI) Q4 Earnings: A Look at Key Metrics

Although the revenue and EPS for Houlihan Lokey (HLI) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com2026-05-06

Houlihan Lokey (HLI) Misses Q4 Earnings and Revenue Estimates

Houlihan Lokey (HLI) came out with quarterly earnings of $1.63 per share, missing the Zacks Consensus Estimate of $1.84 per share. This compares to earnings of $1.96 per share a year ago.

seekingalpha.com2026-05-06

Houlihan Lokey, Inc. (HLI) Q4 2026 Earnings Call Transcript

Houlihan Lokey, Inc. (HLI) Q4 2026 Earnings Call Transcript

businesswire.com2026-05-06

Houlihan Lokey Reports Fiscal Year and Fourth Quarter 2026 Financial Results

LOS ANGELES--(BUSINESS WIRE)--Houlihan Lokey, Inc. (NYSE:HLI) (“Houlihan Lokey” or the “Company”) today reported financial results for its fiscal year and fourth quarter ended March 31, 2026. For the fiscal year, revenues were $2.62 billion, compared with $2.39 billion for the fiscal year ended March 31, 2025. For the fourth quarter ended March 31, 2026, revenues were $636 million, compared with $666 million for the fourth quarter ended March 31, 2025. Net income attributable to Houlihan Lokey,.

globenewswire.com2026-05-04

Lexitas CEO Nishat Mehta to Speak on AI in Litigation Support at 2026 ONE Houlihan Lokey Global Conference

Lexitas CEO to join industry leaders for panel discussion on the impact of AI across litigation support services Lexitas CEO to join industry leaders for panel discussion on the impact of AI across litigation support services

zacks.com2026-04-30

Analysts Estimate Coinbase Global, Inc. (COIN) to Report a Decline in Earnings: What to Look Out for

Coinbase Global (COIN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com2026-04-30

Implied Volatility Surging for Houlihan Lokey Stock Options

Investors need to pay close attention to HLI stock based on the movements in the options market lately.

zacks.com2026-04-29

Earnings Preview: Houlihan Lokey (HLI) Q4 Earnings Expected to Decline

Houlihan Lokey (HLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"HLI delivered Q4’26 results with Revenue of $635.6M and Net Income of $99.8M (EPS $1.50). YoY, Revenue declined (−4.7% vs. 2025-03-31) and Net Income fell (−18.1% vs. 2025-03-31). QoQ, Revenue dipped (−11.4% vs. 2025-12-31) while Net Income declined (−14.3%). Profitability remained healthy but was not consistently trending upward: net margin contracted to ~15.7% in the latest quarter from ~18.3% a year ago, and gross profit margin stayed very high (~98.7%). Operating income margin improved vs. Q3’26 (~22.5% vs. ~24.9% was actually lower; latest is ~22.5%) indicating costs/other items pressured earnings QoQ and YoY. Cash generation improved on a QoQ basis: operating cash flow was $293.0M and free cash flow $286.8M in Q4’26, both higher than Q3’26. Shareholder returns remain balanced: HLI paid $39.2M of dividends (payout ratio ~39%) and repurchased $7.8M of stock in the quarter. Balance sheet resilience looks solid with net cash (net debt −$0.70B) and rising total equity (~$2.45B), while total assets increased to ~$4.31B. Total shareholder return is supported by a positive 1-year price change (+6.84%), but it is not strong enough to classify as high-momentum (>20% 1y_change). The analyst target consensus ($188) sits modestly below the current price ($162.5)."

Revenue Growth

Caution

Revenue fell −11.4% QoQ (from $717.1M to $635.6M) and −4.7% YoY (from $666.4M on 2025-03-31). The trajectory points to deceleration rather than growth.

Profitability

Fair

Net margin is ~15.7% in 2026-03-31 vs ~18.3% in 2025-03-31 (contraction YoY). Net income declined −14.3% QoQ and −18.1% YoY, suggesting earnings pressure despite very high gross profit ratio (~98.7%).

Cash Flow Quality

Positive

Operating cash flow improved to $293.0M (from $217.7M in Q3’26) and free cash flow was $286.8M. Capital intensity appears limited (CapEx ~ $6.3M). Dividends (~$39.2M) are covered by cash flows; buybacks were smaller ($7.8M).

Leverage & Balance Sheet

Good

Net cash position strengthened to net debt of −$0.70B. Total equity increased to ~$2.45B and total assets rose to ~$4.31B, indicating improving balance-sheet resilience.

Shareholder Returns

Neutral

Shareholders received dividends and modest buybacks (Q4 dividends $39.2M; repurchases $7.8M). However, market-driven momentum is only +6.84% over 1 year, below the >20% high-momentum threshold.

Analyst Sentiment & Valuation

Neutral

Consensus price target is $188 vs current $162.5 (suggesting ~+15.6% upside). Valuation metrics show premium multiples (e.g., P/E ~23.9) which can limit upside if earnings keep softening.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Houlihan Lokey delivered a strong FY2026 performance (revenue +10% to $2.6B; adjusted EPS +20% to $7.56) and reported Q4 revenue of $636M with adjusted EPS of $1.63. The key swing factor in the call was Financial Restructuring: management said activity levels materially increased due to new mandates and changes in market dynamics, flipping prior-quarter conservatism into an improved fiscal 2027 outlook, with elevated levels expected to persist. Corporate Finance faced near-term timing headwinds as geopolitical uncertainty extended deal timelines; management does not expect permanent deterioration, but acknowledges variability into early fiscal 2027. On financial quality, adjusted compensation ratio held at 61.5%, while the effective tax rate fell 610 bps to 23.7% due to policy changes. Capital returns included ~$1.4B cash/investments, ~300k shares repurchased in Q4, and a 17% dividend increase to $0.70/share. Analysts pressed most on restructuring recovery, sponsor/price alignment, and AI’s profitability impact.

AI IconGrowth Catalysts

  • Financial Restructuring momentum returned to more normal levels; elevated activity expected to continue into fiscal 2027.
  • Corporate Finance improved transaction metrics across most industry groups; notable backlog growth, with non-U.S. revenues growing significantly faster than U.S.
  • Capital Solutions strong fiscal 2026 performance entering fiscal 2027 with strong backlog and high expectations.

Business Development

  • Closed fiscal Q4 2026 transactions/partnerships welcoming new colleagues from Audere Partners and Mellum Capital.
  • Promoted 25 colleagues to Managing Director in the first quarter of fiscal 2027.
  • Recent acquisition in France supporting differentiated Europe growth (referenced as adding to Europe business).

AI IconFinancial Highlights

  • FY2026 revenue $2.6B (+10% y/y) and adjusted EPS $7.56 (+20% y/y).
  • Q4 2026 revenue $636M; adjusted EPS $1.63.
  • Corporate Finance Q4 revenue $434M (+5% y/y) with 171 transactions closed vs 147; average transaction fee on closed deals decreased.
  • Financial Restructuring Q4 revenue $110M; FY2026 revenue $529M (-3% y/y) with 30 transactions closed vs 21% lower year-over-year; average transaction fee on closed deals decreased.
  • Financial and Valuation Advisory Q4 revenue $91M (+3% y/y); fee events 1,248 vs 1,224 (+2%).
  • Adjusted compensation expense ratio flat at 61.5% vs prior year; reaffirmed long-term target 61.5% for fiscal 2027.
  • Adjusted effective tax rate FY2026 23.7% vs 29.8% FY2025 (-610 bps); driven by policy change (no longer adjusting out stock compensation deductions).
  • Adjusted effective tax rate Q1 fiscal 2027 benefit expected: about half of Q4 fiscal 2026 adjusted rate (vs vesting of shares at grab prices in May).
  • Non-compensation expenses increased 10.5% to $94M in Q4; FY2026 adjusted non-comp ratio ended at 13.9%, with fiscal 2027 expecting similar growth.

AI IconCapital Funding

  • Repurchased approximately 300,000 shares in Q4 under the share repurchase program.
  • Ended quarter with ~$1.4B cash and investments (cash earmarked to cover accrued but unpaid bonuses for FY2026 paid at month-end in November).
  • Board increased quarterly dividend to $0.70/share (+17% vs fiscal 2026 quarterly dividend); first quarter dividend paid in June.
  • Continues to evaluate balance sheet flexibility for acquisitions vs excess cash for repurchases.

AI IconStrategy & Ops

  • Corporate Finance deal timelines extended due to geopolitical uncertainty from the Middle East; management expects this to persist in the near term and to moderate growth in early fiscal 2027 (similar to Q4 impact).
  • Financial Restructuring Q4 impacted by closing timing (two larger transactions extended beyond quarter end); management does not view fee-size changes as a persistent trend.
  • AI/technology: management is investing across front-end, workflow, operations/back office, and 'moonshot' workstreams; technology spend expected to remain consistent and be transferable across Portfolio Valuation/FDA and benefit Corporate Finance/Restructuring.

AI IconMarket Outlook

  • Corporate Finance: expect deal time-line variability to persist; near-term closing timing may moderate Q1 growth, but full-year trajectory remains encouraging.
  • Financial Restructuring: improved outlook for fiscal 2027 driven by materially increased activity levels and recent wins; management expects elevated levels to continue into fiscal 2027 and 'probably beyond.'
  • Financial and Valuation Advisory: Portfolio valuation marks expected to be needed more regularly in contexts like private credit scrutiny; TAM continuing to grow.
  • Adjusted compensation expense ratio: maintain long-term target 61.5% for fiscal 2027.

AI IconRisks & Headwinds

  • Geopolitical uncertainty (Middle East conflict) extending M&A timelines and creating near-term closing volatility.
  • Technology/software impact: management expects software/technology to be affected in fiscal 2027; timing/demand uncertainty persists as clients assess impact.
  • Private credit valuation pressure could affect deal pricing dynamics and activity velocity (though management emphasized pent-up demand).
  • Pricing pressure in FDA business expected to persist (management reiterated it has existed for a decade), though they argue TAM growth outpacing pricing declines.

Q&A: Analyst Interest

  • Restructuring outlook reversal: Management explained the improved Financial Restructuring outlook is the flip side of Corporate Finance troubles, creating restructuring opportunity. They cited newly seen mandates and materially increased activity since last quarter, plus specific recent wins, leading them to confidence in elevated levels next year and beyond.
  • Sponsor activity/transaction velocity and price alignment: Management described sponsor velocity picking up again at the highest level in years, emphasizing that deal initiation momentum is strong even after Middle East/software-related brakes. They acknowledged some assets may be too far from price differentials, but said most deal flow is not in that category.
  • AI implications for FDA/valuation and cost structure: Management said AI is not new to them; they have been investing for years, including through acquisitions (UK example). They expect pricing pressure to continue but argued TAM growth outpaces pricing declines and consolidation benefits larger technology-investing firms.

Sentiment: MIXED

Note: This summary was synthesized by AI from the HLI Q4 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for HLI.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (HLI)

© 2026 Stock Market Info — Houlihan Lokey, Inc. (HLI) Financial Profile